Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Leukapheresis Market Size From 2025 to 2034?

The market size for leukapheresis has experienced substantial growth recently. In 2024, it was valued at $66.8 billion and it is projected to rise to $72.02 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.8%. This growth in the past can be linked to the rising prevalence of leukemia and autoimmune diseases, increased demand for bespoke medicine, advancements in stem cell research, refinement in apheresis technologies, augmented activities in clinical trials, and enhanced awareness of applications in immunotherapy.

Expectations are high for the leukapheresis market, as it is predicted to experience considerable growth in the coming years. By 2029, the market is projected to reach a value of $97.11 billion, with a compound annual growth rate (CAGR) of 7.8%. The anticipated growth within the forecast period is due to factors such as the increased demand for individualized cell therapies, the rise in clinical trials for immuno-oncology, increased use in the field of regenerative medicine, growth in biopharmaceutical manufacturing, better reimbursement policies, and heightened awareness of cell-based research and treatment choices. Key trends for the forecast period comprise improved cell separation technologies, utilization of artificial intelligence for optimizing procedures, the innovation of portable leukapheresis devices, progressive advancements in cell and gene therapy, enhanced methods of donor screening, and the employment of cloud-based systems for data tracking.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24277&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Leukapheresis Market?

The increase in autoimmune diseases is predicted to fuel the leukapheresis market’s expansion in the future. These diseases are characterized by the immune system erroneously assaulting the body’s own healthy tissue. Limited exposure to microbes early in life, coupled with contemporary environmental factors, is disturbing the immune system balance, leading to a rise in autoimmune disorders. Leukapheresis provides a treatment method for these diseases by selectively eliminating the detrimental white blood cells that instigate the immune system’s assault on the body’s tissue. For example, according to November 2024 data from the Germany-based organization, Versorgungsatlas.de, out of 73,241,305 insured individuals in 2022, 6,304,340 had been diagnosed with at least one autoimmune disease. This equates to a raw prevalence rate of 8.61%. As a result, the escalating incidence of autoimmune diseases is driving the leukapheresis market’s growth.

Which Key Market Segments Comprise the Leukapheresis Market and Drive Its Revenue Growth?

The leukapheresis market covered in this report is segmented –

1) By Type: Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis

2) By Product: Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables

3) By Application: Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications

4) By End User: Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers

Subsegments:

1) By Granulocyte Apheresis: Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis

2) By Lymphocyte Apheresis: T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis

3) By Monocyte Apheresis: Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=24277&type=smp

Which Areas Are Leading Regions in the Leukapheresis Market Expansion Across the Globe?

North America was the largest region in the leukapheresis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukapheresis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering theLeukapheresis Market Direction?

Leading businesses in the leukapheresis market are prioritizing innovations such as the creation of GMP-grade leukopaks aimed at improving the quality and effectiveness of cell therapy production. These products, derived from leukapheresis procedures, are processed under rigorous GMP standards, guaranteeing the high viability and functionality of the cells gathered for therapeutic use. One key example is Sanguine Biosciences, a biotechnology company based in the US, who rolled out LeukoCer in November 2024. This is a GMP-grade leukopak product aimed at optimizing workflows and speeding up the development of cell therapy. By offering high-grade starting materials in fresh whole or half packs, produced following rigorous GMP standards, LeukoCer enables researchers to progress their studies and deliver new cell therapies to market quicker.

View the full report here:

https://www.thebusinessresearchcompany.com/report/leukapheresis-global-market-report

How Is the Leukapheresis Market Conceptually Defined?

Leukapheresis is a medical procedure that involves separating and removing white blood cells (leukocytes) from a person’s blood. The remaining components, such as red blood cells and plasma, are then returned to the body. This technique is used to treat conditions involving high white blood cell counts or to collect specific immune cells for research or therapy.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24277

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model